Department Of Infectious Diseases 1
1. Factors associated with fibro-cavernous tuberculosis
2. Very little influenza in the WHO European Region during the 2020/21 season, weeks40 2020 to 8 2021
3. Very little influenza in the WHO European Region during the 2020/21 season, weeks40 2020 to 8 2021
4. Global multi-societies endorsement of the MAFLD definition
5. Global multi-societies endorsement of the MAFLD definition
6. THE COVID-19 VACCINATION ACCEPTANCE/HESITANCY RATE AND ITS DETERMINANTS AMONG HEALTHCARE WORKERS OF 91 COUNTRIES: A MULTICENTER CROSS-SECTIONAL STUDY
7. THE COVID-19 VACCINATION ACCEPTANCE/HESITANCY RATE AND ITS DETERMINANTS AMONG HEALTHCARE WORKERS OF 91 COUNTRIES: A MULTICENTER CROSS-SECTIONAL STUDY
8. Health-Related Quality of Life and Treatment Satisfaction of Patients with Blood Cancer in Kazakhstan: A Cross-Sectional Study
9. Q Fever in Individuals in the Eurasian Continent: A 50-Year Literature Review (1973-2022)
10. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
11. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
12. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
13. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
14. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
15. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
16. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
17. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
18. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
19. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
20. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
21. Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
22. Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey
23. Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey
24. Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey
25. Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey
26. Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey
27. Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study
28. Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study
29. Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study
30. Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study
31. Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study
32. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
33. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
34. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
35. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
36. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
37. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
38. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
39. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
40. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
41. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
42. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
43. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
44. Managing penicillin resistant pneumococcal meningitis: an international id-iri study
45. Managing penicillin resistant pneumococcal meningitis: an international id-iri study
46. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study
47. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study
48. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study
49. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study
50. Acute Respiratory and Influenza Viruses Circulating in Kazakhstan During 2018–2024
1 2